ACS Spring 2026 will take place in Atlanta, GA, and is one of the largest annual gatherings in the chemistry field. The event features thousands of oral presentations spanning a wide range of chemistry specialties, as well as poster sessions showcasing current research. The program also includes the Open Board Session, the Priestley Medalist Address, and the Kavli Lectures, which highlight recent contributions from researchers in the field.
Session
Drug Discovery Aimed at Neglected and Emerging Parasitic Infections
Date: Monday, 23 March 2026
Time: 8:00-12:00
| Time: 8:00 – 8:30 Kinase inhibitors displaying poly-pharmacology against the human malaria parasite Plasmodium falciparum Kelly Chibale, University of Cape Town |
| Time: 8:30 – 9:00 Integrating phenotypic and structure-based strategies: Pyrazolopyridazines for leishmaniasis Lori Ferrins, Northeastern University |
| Time: 9:00 – 9:30 Challenges and opportunities in drug discovery for neglected infectious diseases Luiza Cruz, Drugs for Neglected Diseases initiative |
| Time: 9:30 – 10:00 Thiophen-2-yl-pyrimidines as anti-schistosomal agents: Structure-activity relationship and target investigation Karol Rogelle Francisco, University of California San Diego |
| Time: 10:00 – 10:30 Synthesis driven discovery of inhibitors of neuropathogenic N. fowleri or ‘brain eating amoeba‘ Jennifer Golden, University of Wisconsin-Madison |
| Time: 10:30 – 11:00 Drug discovery at novartis global health: Developing innovative therapies for the treatment of parasitic diseases Christopher Sarko, Novartis Pharmaceuticals Corporation |
| Time: 11:00 – 11:30 Development of selective inhibitors for the bromodomain-containing protein smbrd3 from schistosoma mansoni Fatma Albayrak, University of California Los Angeles |
| Time: 11:30 – 12:00 Optimization of novel benzoxaboroles for the treatment of cryptosporidiosis Marvin Meyers, Saint Louis University |
